Andrej D.
- Country
- Slovakia
- Department
- #4120: Angiologická ambulancia
Research Overview
- Efficacy and Safety of Orforglipron in Participants with Peripheral Artery Disease: A Randomized, Double-Blind, Placebo-Controlled Trial
- Inclisiran for Prevention of Major Adverse Cardiovascular Events in High-Risk Primary Prevention Patients with Atherosclerotic Cardiovascular Disease
- Evaluation of Obicetrapib on Major Adverse Cardiovascular Events in Atherosclerotic Cardiovascular Disease Patients on Maximal Lipid-Modifying Therapy
Data & Insights
Has run more than one trial at 1132 of 1858 partner sites.
Specializations
Cardiovascular Disease Management
Specializes in treating various forms of atherosclerotic cardiovascular disease and heart failure, with particular focus on innovative therapies for patients with reduced ejection fraction. Conducts research on novel treatments for stable angina pectoris and explores preventive strategies for major adverse cardiovascular events.
- Heart Failure Treatment
- Coronary Artery Disease Management
- Cardiovascular Risk Prevention
Cardiac Rhythm Disorders
Focuses on therapeutic approaches for atrial fibrillation, particularly investigating new anticoagulation strategies for stroke prevention. Evaluates novel treatments for preventing cardioembolic events and managing patients unsuitable for conventional oral anticoagulation.
- Stroke Prevention
- Systemic Embolism Management
- Anticoagulation Therapy
Metabolic Cardiovascular Conditions
Investigates treatments for hypertriglyceridemia and its relationship with cardiovascular health. Studies innovative approaches to managing lipid disorders and their impact on cardiovascular outcomes, including research on treatments for elevated lipoprotein(a) levels.
- Lipid Management
- Triglyceride Reduction Therapy
- Cardiovascular Risk Modification
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.